Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Audientes A/S: Q3 2024 Financial Report

Company announcement no. 33-2024November 21, 2024   Audientes A/S (“Audientes” or the “Company”), CVR 36047631, announces its unaudited financial results for Q3 2024. The Company provides updates on progress in its key markets and adjusts its sales and financial objectives for the full year 2024 because some expected sales orders are now likely to first materialize in 2025.Operating Highlights Q3 2024 ·In Q3 2024, Audientes focused on expanding its market presence in China, Japan, India, and Europe by establishing strategic partnerships and collaborations with key entities.

Tele2 announces changes to the Group Leadership Team

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) announces that Yogesh Malik, Executive Vice President and CTIO, will step down from his position effective from today.Yogesh joined Tele2 and the Group Leadership Team in April 2021 and has been responsible for Networks and IT, including the extensive roll-out of Tele2’s award winning 5G network and the major IT transformations that Tele2 has undertaken to have all their brands on one IT platform.    -        I want to thank Yogesh for his important contributions to Tele2. His knowledge and experience have been

Issue of Equity

21 November 2024   Ashoka WhiteOak Emerging Markets Trust plc   Issue of Equity   Ashoka WhiteOak Emerging Markets Trust plc (the ‘Company’) announces that it has issued 150,000 new ordinary shares of one penny each (the ‘Ordinary Shares’) pursuant to its block listing facility. The Ordinary Shares will be issued at a price of 120.0 pence per Ordinary Share, a premium to the prevailing net asset value per Ordinary Share.   Following the issue of Ordinary Shares, the Company's issued share capital will comprise 33,581,795 Ordinary Shares and this is the total number

#24-401 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-400 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Peptonic receives approximately SEK 49.9 thousand through warrants of series TO5

NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, CANADA, OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER ACTIONS BEYOND THOSE REQUIRED BY SWEDISH LAW. PEPTONIC medical AB ("Peptonic" or the "Company") today announces the outcome of the exercise of warrants of series TO5 (”TO5”). In total, 3,839,942 TO5 were exercised, corresponding to approximately 0.18 percent of the total number of outstanding TO5, for

Communique Pehr G. Gyllenhammar

Pehr G. Gyllenhammar passed away at the age of 89 on 21 11 2024, after a period of illness. He passed peacefully in Toronto, Canada, surrounded by his loved ones.   As one of Sweden’s most influential industrialists of the 20th century, he was the face of Volvo for 23 years, serving as the company’s CEO and/or chairman between 1971 and 1994.   Pehr will be remembered for his integrity, courage, independence, visionary leadership and commitment to humanistic values. He leaves behind his beloved daughter, Barrett, and wife Dr Lee Croll. He is predeceased by his first wife,

Result of AGM

FIDELITY ASIAN VALUES PLC  Results of Annual General Meeting LEI: 54930094CXNYINSNOQ96 At the Company's Annual General Meeting held on 21 November 2024, all resolutions were duly passed. The resolutions passed as Special Business were as follows: -  that the Directors be and are hereby authorised to amend the Investment Policy. -  to renew the Directors’ authority to allot a limited number of currently unissued ordinary shares (or sell any ordinary shares held as Treasury shares) for cash; - to issue such shares (including Treasury shares) without first offering them to

poLight ASA receives purchase order for TWedge® wobulator technical samples from a top tier consumer OEM customer

Tønsberg, 21 November 2024 - poLight ASA (OSE: PLT) today announced that the company has received a purchase order worth approximately NOK 500,000 to supply its TWedge®[ ]wobulator technical samples to a top tier consumer OEM customer for an AR/MR application. “Our customer interactions related to TWedge® wobulator technology provide key insights as we define this potential new product,” said Dr. Øyvind Isaksen, CEO of poLight ASA. “TWedge® wobulator is based on the same tunable optics technology platform as our TLens® product used in numerous auto focus imaging systems. While there will

#24-119 ECOMB AB approved for listing at NGM

Nordic Growth Market NGM AB (“NGM“) has, as previously announced, decided to list the shares in ECOMB AB at NGM. The first day of trading has been set to November 25, 2024.   The shares in ECOMB AB have previously been listed at Spotlight Stock Market.   Information regarding the affected instrument:   Listing name: ECOMB Exchange symbol: ECOMB  ISIN-code: SE0004051068 CFI-code: ESVUFR FISN-code: ECOMB/SH Instrument-ID: G962 Tick size table/liquidity band: 2 Number of issued shares: 90 002 469 First day of trading: 2024-11-25  Market-ID: NSME

CasinoRank Explores iGaming Regulation Changes and Their Impact

November 21, 2024 — CasinoRank , a trusted authority in online casino industry, provides insights on regulatory changes shaping the global iGaming market. These changes, spanning multiple jurisdictions, are redefining the landscape for operators, players, and stakeholders worldwide.While many regions are undergoing significant shifts, Germany and the United Kingdom stand out as key examples of markets driving impactful change. In Germany, the Interstate Treaty on Gambling (GlüStV) has introduced new licensing standards, advertising restrictions, and player

Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion

Oslo, November 21st 2024: Lytix Biopharma refers to the release made today by its licensing partner Verrica Pharmaceuticals, announcing the pricing of a USD 42 million underwritten public offering. The offering is expected to close on November 22, 2024, and the gross proceeds from the offering are expected to be approximately USD 42.0 million. Verrica also granted the underwriter an option for a period of 30 days to purchase up to 7,080,000 additional shares. The full announcement can be read via this link: https://verrica.com/press_release/verrica-announces-pricing-of-42-0-million-

Alisa Bank Plc - Managers' Transactions - Salmela

ALISA BANK PLC MANAGER TRANSACTIONS 21.11.2024 AT 16.35 EETPerson subject to the notification requirementName: Salmela, EssiPosition: Other senior managerIssuer: Alisa Bank PlcLEI: 743700VK1NB8HRGTQH74 Notification type: INITIAL NOTIFICATIONReference number: 743700VK1NB8HRGTQH74_20241121111540_19 Transaction date: 2024-11-21Venue not applicableInstrument type: SHAREISIN: FI4000170915Nature of the transaction: SUBSCRIPTION Transaction details(1): Volume: 33000 Unit price: 0.166 EUR Aggregated transactions(1): Volume: 33000 Volume weighted average price: 0.

CapMan redeems its outstanding Notes issued in 2020

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. CapMan PlcStock Exchange Release21 November 2024 at 16.30 p.m. EET CapMan redeems its outstanding Notes issued in 2020 CapMan Plc (the “Company”) will exercise its right to redeem the outstanding share of EUR 3,951,000 of the EUR 50 million notes issued on 2 December 2020 (ISIN: FI4000456132)

Alfa Laval strengthens objectives at the Capital Markets Day 2024

On 21 November 2024, Alfa Laval hosted its Capital Markets Day 2024, and provided an update on the company’s strategic, financial and sustainability priorities.At the annual Capital Markets Day, which took place at one of Alfa Laval’s heat exchanger production sites in San Bonifacio, Italy, Group Management presented an update to the company’s ambitions, strategic priorities and investments in innovation and increased capacity. During the day Alfa Laval announced plans to effectively reach its scope 1 and 2 net zero targets by 2027, three years ahead of the originally announced target year

Alisa Bank Plc - Managers' Transactions - Wallenius

ALISA BANK PLC MANAGER TRANSACTIONS 21.11.2024 AT 16.30 EETPerson subject to the notification requirementName: Wallenius, ChristinaPosition: Other senior managerIssuer: Alisa Bank PlcLEI: 743700VK1NB8HRGTQH74 Notification type: INITIAL NOTIFICATIONReference number: 743700VK1NB8HRGTQH74_20241121111540_20 Transaction date: 2024-11-21Venue not applicableInstrument type: SHAREISIN: FI4000170915Nature of the transaction: SUBSCRIPTION Transaction details(1): Volume: 120482 Unit price: 0.166 EUR Aggregated transactions(1): Volume: 120482 Volume weighted average

Invitation to Investor Webinar on Monday 25th of November at 15:30: Update on commercial status and new opportunities

Copenhagen, Denmark, 21 November 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ invites its shareholders as well as other investors and stakeholders to a webinar, which will take place on Monday, 25th of November 2024 at 15:30 CET.Brain+ will provide an update on commercial activities in the Danish market and share the go-to-market progress in the UK following the launch of Ayla - your CST Assistant. This includes insights into the recent identification of new opportunities within the private care-home market in the UK. The webinar is hosted by CEO Kim Baden-Kristensen, CFO

There are no items matching the current filter
There are no more items matching the current filter
Back to top